Meeting summary: Ethical aspects of whole exome and whole genome sequencing studies (WES/WGS) in rare diseases, Tel Aviv, Israel, January 2013

SID > Fuentes Documentales > Publicaciones Periódicas > Artículos de Revistas > Meeting summary: Ethical aspects of whole exome and whole genome sequencing studies (WES/WGS) in rare diseases, Tel Aviv, Israel, January 2013

Resumen

A recent E-Rare workshop reviewed the ethical aspects of whole exome and whole genome-sequencing studies (WES and WGS, respectively) in rare diseases. Leveraging new genomic technologies, which output vast amounts of known and novel genetic variants, researchers are learning more about the genetic basis and mechanisms involved in rare diseases. In some cases, these findings are translated into diagnostic tools for the benefit of rare disease patients. Among the disclosed data, which can assist in treatment management, incidental findings await, bringing with them ethical concerns for the clinicians, researchers and patients.

Resumen realizado por los autores recogido de la publicación

Publicación

Israel:
Genetics Research,
2013

ISBN

1469-5073

Descripción física

53-56

Serie

Quizás te interese:

Recibe más documentos en tu email

No te pierdas todas nuestras actualizaciones